Bright N Okine Selected Research

Bright N Okine Research Topics

10	Pain (Aches) 03/2022 - 10/2009
4	Hyperalgesia 09/2020 - 10/2012
3	Neuralgia (Stump Neuralgia) 09/2020 - 10/2015
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 07/2015
2	Inflammation (Inflammations) 01/2016 - 07/2015
1	Epilepsy (Aura) 10/2020
1	Migraine Disorders (Migraine) 10/2020
1	Chronic Pain 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015
1	Neuroinflammatory Diseases 07/2015
1	Osteoarthritis 12/2010

8	EndocannabinoidsIBA 03/2022 - 10/2009
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2022 - 01/2017
4	Analgesics (Analgesic Drugs)IBA 01/2019 - 10/2009
3	CB2 Cannabinoid ReceptorIBA 09/2020 - 07/2015
3	Formaldehyde (Formol)FDA Link 02/2020 - 12/2016
3	CannabinoidsIBA 01/2016 - 10/2009
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2016 - 01/2014
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2014 - 10/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2022
1	Biological ProductsIBA 10/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2020
1	Glycerol (Glycerine)FDA LinkGeneric 09/2020
1	JZL 184IBA 09/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2020
1	Protein Isoforms (Isoforms)IBA 02/2020
1	Hormones (Hormone)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	palmidrolIBA 12/2016
1	PesticidesIBA 01/2016
1	Poly I-CIBA 01/2016
1	RotenoneIBA 01/2016
1	pirinixic acidIBA 10/2015
1	EnzymesIBA 01/2014
1	PlasticsIBA 10/2012
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2012
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2012
1	anandamide (arachidonylethanolamide)IBA 10/2012
1	Pharmaceutical PreparationsIBA 10/2012
1	CarrageenanIBA 10/2012
1	SodiumIBA 12/2010

1	Analgesia 03/2022
1	Transcranial Magnetic Stimulation 10/2020
1	Injections 01/2016
1	Therapeutics 10/2015
1	Intra-Articular Injections 12/2010